Anti-Mouse CD226 (480.1) In Vivo Antibody - Low Endotoxin

In stock
Only %1 left
SKU
ICH1222
Add to Compare
$390.00
Add to Wish List
More Information
Concentration 1.0 - 5.0 mg/ml
isotype Rat IgG2a
Host Rat
Target CD226
Species Reactivity Mouse
Purification Method This monoclonal antibody was purified using multi-step affinity chromatography methods such as Protein A or G depending on the species and isotype.
Formulation This antibody is aseptically packaged and formulated in 0.01 M phosphate buffered saline (PBS) pH 7.2, 150 mM NaCl with no carrier protein, potassium or preservatives added.
Purity >95% by SDS-PAGE and HPLC
Endotoxin ≤ 1.0 EU/mg as determined by the LAL method
Storage This Low Endotoxin Functional Formulation conjugate is stable when stored at 2-8°C. Do not freeze.
Applications In vivo
Use Products are for research use only. Not for use in diagnostic or therapeutic procedures.
Write Your Own Review
You're reviewing:Anti-Mouse CD226 (480.1) In Vivo Antibody - Low Endotoxin
Your Rating
Who Viewed This Also Viewed
Polatuzumab Biosimilar - Research Grade
Polatuzumab Biosimilar - Research Grade
$306.00 - $19,500.00
Anti-Mouse LAG-3 (C9B7W) In Vivo Antibody - Low Endotoxin
Anti-Mouse LAG-3 (C9B7W) In Vivo Antibody - Low Endotoxin
$390.00 - $3,702.00
Vedolizumab Biosimilar - Research Grade
Vedolizumab Biosimilar - Research Grade
$306.00 - $19,500.00
Isatuximab Biosimilar - Research Grade
Isatuximab Biosimilar - Research Grade
$306.00 - $19,500.00
Nivolumab Biosimilar - Research Grade
Nivolumab Biosimilar - Research Grade
$306.00 - $19,500.00
Bulk Human IgG1 (IB1) Isotype Control
Bulk Human IgG1 (IB1) Isotype Control
$382.00 - $2,499.00
Eldelumab Biosimilar - Research Grade
Eldelumab Biosimilar - Research Grade
$306.00 - $19,500.00
Ozanezumab Biosimilar - Research Grade
Ozanezumab Biosimilar - Research Grade
$306.00 - $19,500.00
Briakinumab Biosimilar - APC Research Grade
Briakinumab Biosimilar - APC Research Grade
$255.00
Human IgG1 Isotype Control FES
Human IgG1 Isotype Control FES
$306.00 - $5,100.00
Back to Top